Prostate cancer is one of the most common malignant tumors among men and has ranked among the leading cancers in Taiwan in recent years. With an aging population and increasing awareness of early detection, achieving accurate diagnosis at an early stage has become a critical challenge for clinicians and the medical community. Against this backdrop,…

Dr. Ya-Yao Huang, CEO of Primo Biotechnology, was invited to deliver a keynote lecture at the American Association for Cancer Research (AACR), one of the world’s leading organizations dedicated to cancer research. Lecture Topic: Molecular Imaging: Update on PET Imaging in Oncological Research Dr. Huang will share innovative developments in radiopharmaceuticals and their clinical applications,…

Primo has long been dedicated to advancing the field of nuclear medicine, constantly pushing the boundaries of innovation and quality. This year, we are proud to take the stage at the 2025 Annual Conference of Society of Nuclear Medicine, where our latest research has been officially recognized and featured—marking another milestone in our journey of…